TrialJournal of the American Heart Association2020

Evolocumab, a PCSK9-Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia.

Thorsten M Leucker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.